Henry Schein Inc. ($HSIC) Stock Forecast: Down 6.8% Today

What is Henry Schein Inc.?

Henry Schein (HSIC) is a medical equipment and supplies distributor that reported strong financial results for the full year and fourth quarter of 2025. The company has been making strategic moves to enhance its performance and market position.

Why is Henry Schein Inc. going down?

HSIC stock is down 6.8% on Feb 25, 2026 15:12

• A price target increase for Henry Schein to $100 from $90 by Evercore ISI could have initially boosted investor confidence, but the market sentiment shifted bearish despite this positive adjustment.
• Although the company demonstrated strong sales growth in dental and specialty products, concerns about the thin net margin and premium P/E ratio may have led to a bearish movement in the stock.
• The market's response to Henry Schein's better-than-expected fourth-quarter revenue but earnings miss suggests that investors are focusing more on profitability metrics, contributing to the bearish trend.
• The positive financial guidance for 2026 and share repurchase activities might not have been sufficient to offset concerns about the company's profitability and valuation, resulting in the bearish market movement.

HSIC Price Chart

HSIC Technical Analysis

HSIC News

Evercore ISI Adjusts Price Target on Henry Schein to $100 From $90

Evercore ISI has increased its price target for Henry Schein (HSIC) shares to $100 from $90. This adjustment was published on February 25, 2026, at 08:55 am EST. The news comes amid several other analyst adjustments for the medical equipment and supplies distributor.

https://www.marketscreener.com/news/evercore-isi-adjusts-price-target-on-henry-schein-to-100-from-90-ce7e5cdbd189f722

Henry Schein (HSIC) Margin Stays Near 3% And Tests Premium P/E Narrative

Henry Schein (HSIC) reported Q4 2025 revenue of US$3.4 billion and EPS of US$0.86, with a trailing twelve-month revenue of US$13.2 billion and EPS of US$3.29. Despite a 3.0% net margin, which is thin and slightly down from the previous year, the company's shares trade at a premium P/E of 24.7x compared to peers and industry averages. This valuation is challenged by a historical 9.9% annual earnings decline over five years, though analysts foresee future EPS growth of 13.7% annually, largely tied to projected improvements from higher-margin segments and cost savings.

https://simplywall.st/stocks/us/healthcare/nasdaq-hsic/henry-schein/news/henry-schein-hsic-margin-stays-near-3-and-tests-premium-pe-n

Merit Medical Systems (NASDAQ:MMSI) Exceeds Q4 CY2025 Expectations

Merit Medical Systems (NASDAQ:MMSI) announced better-than-expected revenue for Q4 CY2025, with sales up 10.9% year-on-year to $393.9 million, surpassing analyst estimates. Both the full-year revenue guidance and adjusted EBITDA also beat expectations, although non-GAAP profit for the quarter slightly missed consensus estimates. The company showed strong operating margin improvement and impressive long-term EPS growth, despite a minor miss on quarterly adjusted EPS.

https://finviz.com/news/320954/merit-medical-systems-nasdaq-mmsi-exceeds-q4-cy2025-expectations

Henry Schein (HSIC) Stock Trades Up, Here Is Why

Shares of Henry Schein (HSIC), a dental and medical products company, rose 4.8% after reporting better-than-expected fourth-quarter 2025 revenue, despite missing earnings estimates. The company posted quarterly sales of $3.44 billion, a 7.7% increase year over year. This positive market reaction suggests that strong sales growth outweighed the earnings per share miss.

https://finviz.com/news/320827/henry-schein-hsic-stock-trades-up-here-is-why

Henry Schein Reports Growth in Dental and Specialty Product Sales for 2025

Henry Schein Inc. announced strong financial results for the full year and fourth quarter of 2025, with total annual sales reaching $13.2 billion. The company saw significant growth in its global dental, specialty products, and technology segments, attributing the performance to its 2025-2027 BOLD+1 strategic plan. Henry Schein also provided positive financial guidance for 2026 and repurchased 12.1 million shares of common stock, totaling $850 million, in 2025.

https://orthodonticproductsonline.com/industry-news/company-news/henry-schein-2025-dental-specialty-sales-growth/

Trending Today

Henry Schein Inc. Price History

24.01.2026 - HSIC Stock was up 9.7%

• Strong fourth-quarter results, surpassing analyst expectations for both earnings and revenue, contributed to the bullish market movement.
• An optimistic fiscal 2026 outlook, forecasting adjusted EPS between $5.23 and $5.37 and total sales growth of 3% to 5%, further fueled investor confidence in the company.
• The positive reception of biosimilars in the healthcare industry may have also boosted sentiment towards Henry Schein, given its involvement in the medical supplies sector.
• The combination of robust financial performance and positive industry trends likely drove the bullish movement in Henry Schein's stock today.

24.01.2026 - HSIC Stock was up 6.7%

• HSIC stock experienced a bullish movement, jumping over 8% following the release of its Q4 earnings report, which beat analyst estimates for both earnings and sales.
• Despite missing EPS estimates, the company's revenue growth across various segments, such as Dental, Medical, Specialty Products, and Technology, contributed to the positive market sentiment.
• The contraction in margins due to increased costs of sales and expenses might be a concern for investors, but the overall strong financial performance and revenue beats likely drove the stock price higher.
• The broader market trend of U.S. stocks seeing gains on Tuesday, coupled with positive quarterly results from multiple companies, contributed to the bullish movement in Henry Schein's stock.

04.10.2025 - HSIC Stock was up 13.7%

• HSIC stock experienced a strong bullish movement today following the release of their Q3 earnings report.
• The earnings and revenue beats by +8.66% and +2.02% respectively have exceeded market expectations, indicating strong performance by the company.
• Investors are likely optimistic about the future prospects of HSIC, as the positive results suggest continued growth and profitability in the healthcare industry.
• The beat in earnings and revenues could attract more investors to the stock, driving up demand and pushing the stock price higher.

04.10.2025 - HSIC Stock was up 10.4%

• HSIC stock saw a surge following the announcement of better-than-expected Q3 earnings and revenue, exceeding analyst estimates by a notable margin.
• Boosting investor confidence, the company's decision to raise its 2025 outlook due to solid business momentum played a significant role in the stock's upward movement.
• The positive surprises in earnings and revenue point towards robust performance and growth potential for Henry Schein, eliciting increased optimism among investors and driving the stock price higher.

05.04.2025 - HSIC Stock was up 5.0%

• Despite missing revenue expectations, Henry Schein's Q1 earnings beat estimates, showing resilience in its business fundamentals.
• The rise in Global Specialty Products sales, driven by implants, biomaterials, and acquisitions, indicates a strong performance in key segments.
• The CEO's confidence in the business fundamentals suggests a positive outlook for the stock, leading to a strong bullish movement today.

25.01.2026 - HSIC Stock was down 6.8%

• A price target increase for Henry Schein to $100 from $90 by Evercore ISI could have initially boosted investor confidence, but the market sentiment shifted bearish despite this positive adjustment.
• Although the company demonstrated strong sales growth in dental and specialty products, concerns about the thin net margin and premium P/E ratio may have led to a bearish movement in the stock.
• The market's response to Henry Schein's better-than-expected fourth-quarter revenue but earnings miss suggests that investors are focusing more on profitability metrics, contributing to the bearish trend.
• The positive financial guidance for 2026 and share repurchase activities might not have been sufficient to offset concerns about the company's profitability and valuation, resulting in the bearish market movement.

25.01.2025 - HSIC Stock was down 4.5%

• The stock of Henry Schein (HSIC) displayed strong bearish movement today.
• Even though Q4 earnings estimates were met, the stock faced a notable decline, suggesting that investors expected stronger performance.
• Despite slightly surpassing revenue expectations, concerns about future growth prospects likely contributed to the significant market downturn.
• Investors responded negatively to the Q4 outlook and key metrics, triggering a sell-off in the stock.

15.00.2026 - HSIC Stock was up 3.9%

• The appointment of Frederick M. Lowery, a seasoned executive with a background in the healthcare industry, as the new CEO of Henry Schein has brought a fresh perspective to the company's leadership.
• The strategic shift in leadership, with Stanley M. Bergman transitioning to Chairman, signifies a governance reframe that aims to drive operational efficiencies and growth in specialty products and technology.
• Investors seem optimistic about the potential impact of the new CEO's expertise in distribution and product businesses on Henry Schein's strategic goals, leading to a bullish market movement for the stock.

05.07.2025 - HSIC Stock was down 5.3%

• The decline in HSIC stock today might be a result of investors taking profits in anticipation of the upcoming Q2 earnings announcement.
• Despite the likelihood of surpassing earnings expectations, some market participants seem to have opted to unload their positions, contributing to the stock's downward trajectory.
• This pattern could signal a scenario where investors who purchased shares in anticipation of positive earnings are now divesting to secure gains prior to the official release.

05.07.2025 - HSIC Stock was down 9.2%

• HSIC stock experienced downward movement after falling short of Q2 earnings estimates by 6.8%.
• The company surpassed revenue expectations with a 3.2% growth and exhibited strength across key segments, but the market responded negatively to the earnings miss.
• Concerns about future earnings potential and growth prospects may be driving the downward pressure on HSIC stock for investors.
• The mixed results of earnings and revenues could be causing uncertainty among investors, leading to a sell-off of HSIC shares in the current trading session.

10.06.2025 - HSIC Stock was up 2.6%

• Investor confidence in HSIC is high, attributed to the successful performance of Henry Schein One.
• Potential obstacles for the company include macroeconomic pressures and strong competition.
• Nevertheless, the optimistic outlook on HSIC appears to have overshadowed these challenges, resulting in a bullish trend in the stock today.

06.04.2025 - HSIC Stock was up 5.2%

• Despite mixed results for the first quarter, Henry Schein's stock showed bullish movement, reflecting investor confidence.
• The better-than-expected adjusted EPS likely bolstered the bullish trend, demonstrating effective earnings management.
• The shortfall in sales expectations may have been outweighed by the positive earnings surprise, fostering positive market sentiment.
• Overall, the CEO's confidence in the business fundamentals following the mixed earnings report seemed to reassure investors and influence the stock's bullish movement.